Concepedia

Wayne Brailsford

WB

Statistics

Publications

5

Citations

152

H-Index

5

Active since

1998

Affiliations

AstraZeneca (United Kingdom)(Current)

University of East Anglia

AstraZeneca (Sweden)

Wayne Brailsford is an author at AstraZeneca (United Kingdom) specializing in organic chemistry, catalysis, and fe(iii) reduction.

Publications per year

1998–2024

5

Publications

5

Discovery and Optimization of a Series of Carbazole Ureas as NPY5 Antagonists for the Treatment of Obesity

Scott Boyer, Wayne Brailsford, David R. Brittain et al. · Journal of Medicinal Chemistry · 2002 · 66 citations · Full text

, , +15

Fe(III) mediated oxidative radical cyclisation of cyclopropanone acetals

Kevin I. Booker‐Milburn, Andy Barker, Wayne Brailsford et al. · Tetrahedron · 1998 · 37 citations · Full text

, , +12

A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of <i>Pseudomonas aeruginosa</i> in Patients with Bronchiectasis

Merete Long, Amy Gilmour, Margaret Kehl et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · 25 citations · Full text

, , +15

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease

Muhammad Waqas Sadiq, Sara Asimus, Maria G. Belvisi et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text

, , +16

Diastereoselective Fe(III) mediated oxidative cyclisation reactions of cyclopropanone acetals

Kevin I. Booker‐Milburn, Andy Barker, Wayne Brailsford · Tetrahedron Letters · 1998 · 11 citations

, , +14

1–5 of 5